NCT06548516

Brief Summary

The goal of this clinical trial is to determine if diode laser treatment can improve post-operative outcomes compared to conventional scalpel technique in systemically healthy, non-smoking adults aged 18-45 years with aberrant papillary frenum attachment. The main questions it aims to answer are: Does diode laser treatment result in lower post-operative pain compared to the conventional scalpel technique? Does diode laser treatment result in better periodontal healing outcomes compared to the conventional scalpel technique? Researchers will compare the diode laser surgery group to the conventional scalpel surgery group to see if there are differences in pain and healing. Participants will: Undergo a frenectomy procedure using either a diode laser or a conventional scalpel. Receive oral hygiene instructions and post-operative care recommendations. Have their periodontal parameters measured at baseline, 6 weeks, and 6 months post-operation. Record their pain levels using a visual analogue scale on specified post-operative days.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

August 7, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

August 7, 2024

Last Update Submit

August 7, 2024

Conditions

Keywords

Maxillary Labial FrenumFrenectomy

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain

    Pain will be evaluated using the visual analogue scale (VAS).The scale will be comprised of a horizontal line with values ranging from '0' to '10', where '0' indicates the absence of pain and '10' indicates the presence of severe discomfort.

    postoperative days 1, 3, 7, 14, 21, and 28.

  • Postoperative tissue healing

    Tissue healing will be assessed by Z.T.E using the following scoring system: * Score 1: Complete epithelialization * Score 2: Incomplete epithelialization * Score 3: Presence of ulcer * Score 4: Tissue defect or necrosis

    postoperative days 7 and 30 after surgery,

Study Arms (2)

Control group (conventional scalpel surgery)

ACTIVE COMPARATOR

After administering local infiltrative anesthesia with articaine hydrochloric acid combined with epinephrine 1:100,000, the frenum will be grasped with a straight hemostat positioned in the vestibule. The tissue adjacent to the upper and lower surfaces of the hemostat will then be incised using a no.15 scalpel. The excised diamond-shaped portion of the frenum will be removed with the hemostat. Subsequently, a horizontal incision will be made on the periosteum with a scalpel to prevent fiber reattachment. The wound site will be primarily closed using absorbable sutures (4/0, Pegelak), which will be removed one week post-operatively.

Procedure: Control group (conventional scalpel surgery)

Diode laser group

EXPERIMENTAL

The frenectomy procedure will be performed under local infiltrative anesthesia, specifically articaine hydrochloric acid with epinephrine 1:100,000. A straight hemostat, similar to that used in the C group, will be employed to secure the frenum. Laser energy will be applied to the upper and lower sections of the frenum adjacent to the hemostat, utilizing a diode laser device equipped with a 400 µm diameter, plain-ended optical fiber tip. Frenectomy will performed with a 980 nm diode laser with 1.7 W power in continuous wave mode.The wound site will be allowed to heal by secondary intention without the application of sutures.

Procedure: Diode laser group

Interventions

The patients in the control group will undergo frenectomy using conventional scalpel surgery.

Control group (conventional scalpel surgery)

The patients in the laser group will undergo frenectomy using a diode laser.

Diode laser group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Systemically healthy
  • Nonsmoker
  • No periodontal treatment received in the last 3 months
  • Having at least 20 teeth
  • Presence of at least central incisors, lateral incisors, and canines in the maxilla
  • Not pregnant or breastfeeding
  • No psychiatric, mental, or physical impairments
  • Diagnosed with gingival health based on the "World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions
  • Consent to participate in the study.

You may not qualify if:

  • Any systemic disease that could interfere with the wound healing process (e.g., diabetes mellitus and HIV infection)
  • Smoking
  • Use of antibiotics, anti-inflammatory drugs, or any other medication in the last 6 months that could affect the study's outcome
  • Any hypersensitivity reactions to paracetamol
  • Any physical limitations or restrictions that could impede normal oral hygiene procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necmettin Erbakan University, dentistry Faculty

Konya, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • zeynep taştan eroğlu

    Necmettin Erbakan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

zeynep taştan eroğlu

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Patients in the C group underwent primary wound healing with sutures, whereas patients in the L group did not get any sutures. Therefore, neither the clinicians (Z.T.E and K.Y) nor the patients were kept unaware of the study's details over the entire duration
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

August 7, 2024

First Posted

August 12, 2024

Study Start

April 1, 2024

Primary Completion

August 1, 2024

Study Completion

September 1, 2024

Last Updated

August 12, 2024

Record last verified: 2024-08

Locations